Newspoint on MSN
Brain hemorrhage: Why does it happen? Learn from experts its causes, types, and the most important prevention methods.
Causes of Brain Hemorrhage: A brain hemorrhage is an emergency situation that can be fatal if the patient does not receive timely treatment. Let us explain its symptoms. Brain haemorrhage Early Signs ...
Though recombinant factor VIIa didn’t improve outcomes overall, treating very early and in those with a spot sign on CT may ...
Common causes of postmenopausal bleeding include atrophy and fibroids. Learn about risk factors, treatments, and when to ...
The factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major or minor bleeding in patients ...
More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...
Ultrasonography-guided cyanoacrylate injection is more effective than direct endoscopic injection for treating bleeding in gastric varices with spontaneous shunts.
Nagarkurnool: A 30-year-old man, Naresh M., from Nagar Kurnool district, who sustained severe head injuries in a road ...
2don MSN
Synthetic protein potentially improves outcomes for select intracerebral hemorrhage patients
Results from the largest-ever clinical trial of its kind found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding ...
Clinical trial results indicate a protein, rFVIIa, may benefit certain stroke patients when administered quickly, with a focus on acute intracerebral hemorrhage treatments.
An ovarian cyst rupture can cause sudden pain, bleeding, and other symptoms. Learn the signs, treatments, and what to expect after an ovarian cyst ruptures.
ABP News on MSN
World Cancer Day 2026: Persistent Pelvic Pain And Bleeding — Recognising Early Signs Of Cervical Cancer
(By Dr. Vijay Karan Reddy) Cervical cancer is one of the few cancers where early detection can truly change outcomes, yet it ...
If approved, marstacimab would be the first non-factor prophylactic treatment indicated for pediatric patients aged 6 to 11 years with hemophilia B.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results